A Randomized, Multicenter, Double-blind, Placebo-Controlled, Multiple Ascending Dose Study of the Safety, Tolerability, PK, PD, and Clinical Efficacy of ATN-103 Administered to Japanese Subjects With Active RA on a Background of MTX.

Trial Profile

A Randomized, Multicenter, Double-blind, Placebo-Controlled, Multiple Ascending Dose Study of the Safety, Tolerability, PK, PD, and Clinical Efficacy of ATN-103 Administered to Japanese Subjects With Active RA on a Background of MTX.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 03 Sep 2013

At a glance

  • Drugs Ozoralizumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 27 Sep 2010 Company added as trial sponsor/affiliate as reported by ClinicalTrials.gov.
    • 11 Jun 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 03 Apr 2010 Status changed from recruiting to not yet recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top